Cadisegliatin

N/A

Report date: 2025/05/21 20:00:31
NME

Base Information

Drug NameCadisegliatin
Drug Alias NameTTP-399GK1-399TTP399
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucokinase activators
TargetsGlucokinase
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesVtv Therapeutics
China Registration ClassN/A

Develop Information

Inactive CompaniesVtv Therapeutics Inc
Active IndicationsDiabetes Mellitus, Type 1
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A